Suppr超能文献

错配和互补 DNA 与小沟结合物的配合物。通过改进的羟基自由基切割方法在核苷酸分辨率下的结构。

Complexes of mismatched and complementary DNA with minor groove binders. Structures at nucleotide resolution via an improved hydroxyl radical cleavage methodology.

机构信息

Chemistry Department, Wesleyan University, Middletown, CT 06459, USA.

出版信息

Mutat Res. 2011 Nov 27;726(1):47-53. doi: 10.1016/j.mrgentox.2011.08.004. Epub 2011 Aug 27.

Abstract

Tumor cell lines can replicate faster than normal cells and many also have defective DNA repair pathways. This has lead to the investigation of the inhibition of DNA repair proteins as a means of therapeutic intervention. An alternative approach is to hide or mask damaged DNA from the repair systems. We have developed a protocol to investigate the structures of the complexes of damaged DNA with drug like molecules. Nucleotide resolution structural information can be obtained using an improved hydroxyl radical cleavage protocol. The use of a dT(n) tail increases the length of the smallest fragments of interest and allows efficient co-precipitation of the fragments with poly(A). The use of a fluorescent label, on the 5' end of the dT(n) tail, in conjunction with modified cleavage reaction conditions, avoids the lifetime and other problems with (32)P labeling. The structures of duplex DNAs containing AC and CC mismatches in the presence and absence of minor groove binders have been investigated as have those of the fully complementary DNA. The results indicate that the structural perturbations of the mismatches are localized, are sequence dependent and that the presence of a mismatch can alter the binding of drug like molecules.

摘要

肿瘤细胞系比正常细胞复制得更快,许多肿瘤细胞系的 DNA 修复途径也存在缺陷。这促使人们研究抑制 DNA 修复蛋白作为治疗干预的一种手段。另一种方法是将受损的 DNA 隐藏或掩盖起来,使其免受修复系统的影响。我们已经开发了一种方案来研究受损 DNA 与类似药物分子的复合物的结构。使用改良的羟基自由基切割方案可以获得核苷酸分辨率的结构信息。使用 dT(n)尾巴可以增加感兴趣的最小片段的长度,并允许与 poly(A)有效地共沉淀片段。在 5' 端使用荧光标记,结合修饰的切割反应条件,可以避免 (32)P 标记的寿命和其他问题。已经研究了含有 AC 和 CC 错配的双链 DNA 的结构,以及完全互补的 DNA 的结构。结果表明,错配的结构扰动是局部的、序列依赖性的,并且错配的存在可以改变类似药物分子的结合。

相似文献

3
Mismatch repair deficiency is associated with resistance to DNA minor groove alkylating agents.
Br J Cancer. 1999 May;80(3-4):338-43. doi: 10.1038/sj.bjc.6690360.
4
6
DNA bending propensity in the presence of base mismatches: implications for DNA repair.
J Phys Chem B. 2013 May 23;117(20):6194-205. doi: 10.1021/jp403127a. Epub 2013 May 10.
7
Repair of oxidative DNA damage: mechanisms and functions.
Cell Biochem Biophys. 2001;35(2):141-70. doi: 10.1385/CBB:35:2:141.
10
Effect of T·T Mismatch on DNA Dynamics Probed by Minor Groove Binders: Comparison of Dynamic Stokes Shifts of Hoechst and DAPI.
J Phys Chem B. 2017 Dec 7;121(48):10735-10748. doi: 10.1021/acs.jpcb.7b06937. Epub 2017 Oct 2.

引用本文的文献

本文引用的文献

1
PARP inhibitors in oncology: a new synthetic lethal approach to cancer therapy.
Acta Clin Belg. 2011 Jan-Feb;66(1):2-9. doi: 10.2143/ACB.66.1.2062507.
2
[DNA repair pathways and non-small cell lung cancer: clinical perspectives].
Bull Cancer. 2011 Mar;98(3):305-22. doi: 10.1684/bdc.2011.1327.
3
Synthetic lethality: exploiting the addiction of cancer to DNA repair.
Blood. 2011 Jun 9;117(23):6074-82. doi: 10.1182/blood-2011-01-313734. Epub 2011 Mar 25.
4
Rad51 inhibition is an effective means of targeting DNA repair in glioma models and CD133+ tumor-derived cells.
Neuro Oncol. 2011 May;13(5):487-99. doi: 10.1093/neuonc/nor010. Epub 2011 Mar 1.
5
The clinical development of inhibitors of poly(ADP-ribose) polymerase.
Ann Oncol. 2011 Jan;22 Suppl 1:i53-9. doi: 10.1093/annonc/mdq667.
6
Targeting hypoxic cells through the DNA damage response.
Clin Cancer Res. 2010 Dec 1;16(23):5624-9. doi: 10.1158/1078-0432.CCR-10-0286. Epub 2010 Sep 27.
7
Targeting synthetic lethality in DNA damage repair pathways as an anti-cancer strategy.
Curr Drug Targets. 2010 Oct;11(10):1336-40. doi: 10.2174/1389450111007011336.
8
Targeting base excision repair as a sensitization strategy in radiotherapy.
Semin Radiat Oncol. 2010 Oct;20(4):241-9. doi: 10.1016/j.semradonc.2010.05.005.
9
Harnessing the complexity of DNA-damage response pathways to improve cancer treatment outcomes.
Oncogene. 2010 Nov 18;29(46):6085-98. doi: 10.1038/onc.2010.407. Epub 2010 Sep 6.
10
Targeting poly(ADP-ribose) polymerase activity for cancer therapy.
Cell Mol Life Sci. 2010 Nov;67(21):3649-62. doi: 10.1007/s00018-010-0490-8. Epub 2010 Aug 20.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验